(which operates as Hims and Hers) Location: San Francisco, CaliforniaStore Websites: and Letter Date: September 9, 2025FDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Types of Products Sold: Prescribes and sells compounded semaglutide, tirzepatide and other compounded productsType of Warning: Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetFDA Warning: The website makes false claims about compounded drug products, including: Same active ingredient as Ozempic and Wegovy and Clinically proven ingredients. The claims imply that the products are the same as an FDA-approved product when they are not
Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data
Recordkeeping and Audits Maintain complete medical records: patient evaluation, labs, dosing records, follow-ups, side effects, consent forms
GLP-1 obesity drugs provide a twofold benefit
The last two weeks have been a very testing time for the society
Boosts Natural Energy Fights fatigue by supporting red blood cell production and healthy metabolism, without the crash of stimulants
